Literature DB >> 29969717

Nox4 in renal diseases: An update.

Qin Yang1, Fan-Rong Wu1, Jia-Nan Wang1, Li Gao1, Ling Jiang1, Hai-Di Li1, Qiuying Ma1, Xue-Qi Liu1, Biao Wei1, Luyu Zhou1, Jiagen Wen2, Tao Tao Ma2, Jun Li2, Xiao-Ming Meng3.   

Abstract

Reactive oxygen species derived from NADPH oxidase contribute to a wide variety of renal diseases. Nox4, the major NADPH isoform in kidney, produces mainly H2O2 that regulates physiological functions. Nox4 contributes to redox processes involved in diabetic nephropathy, acute kidney injury, obstructive nephropathy, hypertensive nephropathy, renal cell carcinoma and other renal diseases by activating multiple signaling pathways. Although Nox4 is found in a variety of cell types, including epithelial cells, podocytes, mesangial cells, endothelial cells and fibroblasts, its role is not clear and even controversial. In some conditions, Nox4 protects cells by promoting cell survival in response to harmful stimuli. In other scenarios it induces cell apoptosis, inflammation or fibrogenesis. This functional variability may be attributed to distinct cell types, subcellular localization, molecular concentrations, disease type or stage, and other factors yet unexplored. In this setting, we reviewed the function and mechanism of Nox4 in renal diseases, highlighted the contradictions in Nox4 literature, and discussed promising therapeutic strategies targeting Nox4 in the treatment of certain types of renal diseases.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fibrosis; Inflammation, apoptosis; NADPH oxidases 4; Reactive oxygen species

Mesh:

Substances:

Year:  2018        PMID: 29969717     DOI: 10.1016/j.freeradbiomed.2018.06.042

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  29 in total

1.  Novel Regulators and Targets of Redox Signaling in Pulmonary Vasculature.

Authors:  Zdravka Daneva; Victor E Laubach; Swapnil K Sonkusare
Journal:  Curr Opin Physiol       Date:  2019-05-09

Review 2.  Signaling pathways of chronic kidney diseases, implications for therapeutics.

Authors:  Qian Yuan; Ben Tang; Chun Zhang
Journal:  Signal Transduct Target Ther       Date:  2022-06-09

3.  LncRNA MALAT1 Aggravates Renal Tubular Injury via Activating LIN28A and the Nox4/AMPK/mTOR Signaling Axis in Diabetic Nephropathy.

Authors:  Panai Song; Yinyin Chen; Zhiwen Liu; Hong Liu; Li Xiao; Lin Sun; Jiali Wei; Liyu He
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

4.  NOX4-dependent regulation of ENaC in hypertension and diabetic kidney disease.

Authors:  Tengis S Pavlov; Oleg Palygin; Elena Isaeva; Vladislav Levchenko; Sherif Khedr; Gregory Blass; Daria V Ilatovskaya; Allen W Cowley; Alexander Staruschenko
Journal:  FASEB J       Date:  2020-08-16       Impact factor: 5.191

5.  Maximum reproductive lifespan correlates with CD33rSIGLEC gene number: Implications for NADPH oxidase-derived reactive oxygen species in aging.

Authors:  Naazneen Khan; Stuart K Kim; Pascal Gagneux; Laura L Dugan; Ajit Varki
Journal:  FASEB J       Date:  2019-12-24       Impact factor: 5.191

6.  Smad3-Targeted Therapy Protects against Cisplatin-Induced AKI by Attenuating Programmed Cell Death and Inflammation via a NOX4-Dependent Mechanism.

Authors:  Qin Yang; Li Gao; Xiao-Wei Hu; Jia-Nan Wang; Yao Zhang; Yu-Hang Dong; Hui Yao Lan; Xiao-Ming Meng
Journal:  Kidney Dis (Basel)       Date:  2021-02-05

7.  Dopamine D5 receptor-mediated decreases in mitochondrial reactive oxygen species production are cAMP and autophagy dependent.

Authors:  Hewang Lee; Xiaoliang Jiang; Imran Perwaiz; Peiying Yu; Jin Wang; Ying Wang; Maik Hüttemann; Robin A Felder; David R Sibley; Brian M Polster; Selim Rozyyev; Ines Armando; Zhiwei Yang; Peng Qu; Pedro A Jose
Journal:  Hypertens Res       Date:  2021-04-05       Impact factor: 5.528

Review 8.  NOX5: Molecular biology and pathophysiology.

Authors:  Rhian M Touyz; Aikaterini Anagnostopoulou; Francisco Rios; Augusto C Montezano; Livia L Camargo
Journal:  Exp Physiol       Date:  2019-03-18       Impact factor: 2.969

Review 9.  Mitochondrial Activity and Skeletal Muscle Insulin Resistance in Kidney Disease.

Authors:  Jane E Carré; Charles Affourtit
Journal:  Int J Mol Sci       Date:  2019-06-05       Impact factor: 5.923

10.  Empagliflozin attenuates acute kidney injury after myocardial infarction in diabetic rats.

Authors:  Atsushi Kuno; Yukishige Kimura; Masashi Mizuno; Hiroto Oshima; Tatsuya Sato; Norihito Moniwa; Marenao Tanaka; Toshiyuki Yano; Masaya Tanno; Takayuki Miki; Tetsuji Miura
Journal:  Sci Rep       Date:  2020-04-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.